Similar articles

• [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].

  Lucivero G, Dammacco F, Bonomo L. Lucivero G, et al. Recenti Prog Med. 1977 Sep;63(3):275-88. Recenti Prog Med. 1977. PMID: 413174 Italian. No abstract available.
• Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.

  Carson DA, Wasson DB, Lakow E, Kamatani N. Carson DA, et al. Adv Exp Med Biol. 1984;165 Pt B:133-9. doi: 10.1007/978-1-4757-0390-0_27. Adv Exp Med Biol. 1984. PMID: 6426261 No abstract available.
• Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.

  Carson DA, Kaye J. Carson DA, et al. Ciba Found Symp. 1978;(68):115-33. doi: 10.1002/9780470720516.ch8. Ciba Found Symp. 1978. PMID: 115660 Review.
• Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.

  Cohen A, Gudas LJ, Ullman B, Martin DW Jr. Cohen A, et al. Ciba Found Symp. 1978;(68):101-14. doi: 10.1002/9780470720516.ch7. Ciba Found Symp. 1978. PMID: 115659 No abstract available.
• Biochemistry of diseases of immunodevelopment.

  Martin DW Jr, Gelfand EW. Martin DW Jr, et al. Annu Rev Biochem. 1981;50:845-77. doi: 10.1146/annurev.bi.50.070181.004213. Annu Rev Biochem. 1981. PMID: 6267992 Review. No abstract available.